AI-generated analysis. Always verify with the original filing.
Clarus Corporation reported Q4 2025 sales of $65.4 million, adjusted EBITDA of $1.2 million, and full year 2025 sales of $250.4 million with adjusted EBITDA of $1.1 million. The company provided 2026 guidance of $255-265 million in sales and $9-11 million in adjusted EBITDA, highlighting its debt-free balance sheet and simplification strategy.
Event Type
Disclosure
Mandatory
Variant
8-K
of this Current Report on Form 8-K (including Exhibits 99.1 and 99.2) shall not be deemed “filed” for purposes of Section 18 of the Securities Act of 1934, as a
. Financial Statements and Exhibits (d) Exhibits. Exhibit Description 99.1 Press Release dated March 5, 2026 (furnished only). 99.2 Slide Presentation for Confe
| Metric | Value | Basis |
|---|---|---|
| Sales | $65.40 | |
| Gross Margin | 27.7% | GAAP |
| Adjusted Gross Margin | 33.6% | Non-GAAP |
| Loss from Continuing Operations | $-31.30 | GAAP |
| Diluted EPS from Continuing Operations | $-0.81 | GAAP |
| Adjusted Net Income | $3.60 | Non-GAAP |
| Adjusted EBITDA | $1.20 | Non-GAAP |
| Sales | $250.40 | |
| Gross Margin | 33.1% | GAAP |
| Adjusted Gross Margin | 34.9% | Non-GAAP |
| Loss from Continuing Operations | $-46.60 | GAAP |
| Diluted EPS from Continuing Operations | $-1.21 | GAAP |
| Adjusted Income from Continuing Operations | $3.70 | Non-GAAP |
| Adjusted EBITDA | $1.10 | Non-GAAP |